🚨Exciting News! #JSCAI is accepted for PubMed Central Indexing!🎉 Read @AlexandraLansky's editorial: ➡️doi.org/10.1016/j.jscai.2024… 📢This significant milestone boosts our authors' visibility, citation rates, and recognition by making all articles more accessible to researchers and practitioners. ♥️Thank you to our Editors, Authors, Reviewers, and everyone for their unwavering support in making this possible. @SCAI

📖LAAO vs OAC in AF: Bayesian meta-analysis of 6 RCTs (7,004 pts). High probability #LAAO↑ ischemic stroke, but absolute risk small & offset by↓ hemorrhagic stroke. #AFib ➡️jscai.org/article/S2772-9303… @jaygirimd

Edge to edge repair in SAM-mediated LVOT obstruction case series by @markjzorman et al. authors.elsevier.com/sd/arti… @MyJSCAI

📖Early, preventive LV unloading with single–inflow cannula LAVA-ECMO lowered LV overload & improved 30-day survival in cardiogenic #shock. #LAVAECMO #LVUnloading ➡️jscai.org/article/S2772-9303… @lionskiner

📖In complex #CAD, #AI–Heart Team agreement is higher when narrative inputs are used—75% vs 35% with structured inputs. Discordance was associated with higher MACE risk and may reflect greater patient complexity. ➡️jscai.org/article/S2772-9303…

🫀 Explore evolving approaches to #PulmonaryEmbolism in a new @MyJSCAI Editor-in-Chief curated collection from @AlexandraLansky, MD, MSCAI. Discover evidence and clinical insights on PE diagnosis, risk stratification, and interventional management. Explore the collection ➡️ jscai.org/Pulmonary-Embolism #InterventionalCardiology #CardioX

Among the criticisms of #CTO #PCI is the higher risk compared to regular PCI procedures. This perception stems from the procedure's higher complexity. The unmeasured factor is that CTO PCI is usually performed by operators who can identify and treat possible complications faster and have the awareness to prevent problems or manage them. Our study from the National Trinetix database @MyJSCAI, led by @AdhamGR97 and @MohamedDomaa, compared 30-day outcomes between CTO PCI and ELECTIVE (non-MI) non-CTO PCI, and also trended outcomes over three recent periods (2014-2017, 2018-2021, 2022-2025). Our major findings are as follows 1-CTO PCI risk of pericardiocentesis was higher than non-CTO PCI (0.2% vs 0.09%) but remains very small at 0.2% 2-CABG after CTO PCI was higher than non-CTO PCI; we could not determine the cause, but it was mostly related to failure and the need for revascularization rather than complications. Also, the trend of CABG after CTO PCI has been decreasing. 3-Finally, none of this led to adverse outcomes, as there was absolutely no difference in mortality between the two groups. In the hands of experienced operators, CTO PCI can be safe and effective. sciencedirect.com/science/ar… #CardioX #ACCFIT

Death tied to aortic stenosis are declining but progress has not been equal. Analysis of US data from 1999-2024 shows persistent disparities in AS-related mortality by demographic and geographic groups. @MyJSCAI Read more: bit.ly/4qIA39c

Featured in @CardioBusiness : Helena Smith and @EricSecemskyMD’s @MyJSCAI editorial describes the potential value of optical coherence tomography (OCT) in below-the-knee endovascular interventions. 🔗 Read the full editorial here: jscai.org/article/S2772-9303…

🆕📢One-Year Outcomes from the FORWARD #PAD IDE and Mini S feasibility studies of the novel Javelin #IVL Catheter ➡️jscai.org/article/S2772-9303… @JDCorlMD @nicolas_shammas @PeterSoukas

High-risk pulmonary embolism still carried just 67.8% one-year survival in real-world data. In @MyJSCAI, @RadiologyUcla's Dr. @JonnyMoriarty & collaborators map PE care across 54 US sites and 11,612 patients. doi.org/10.1016/j.jscai.2026…

Evaluation and Treatment of Myocardial Bridging by Clinical Phenotype sciencedirect.com/science/ar… @MyJSCAI @MortonKern

🆕📖Economic analysis based on the #ZPEERLESS RCT shows large-bore mechanical thrombectomy is cost-effective compared to catheter-directed thrombolytics for intermediate-risk #PE, providing lifetime cost savings & improved #QoL. ➡️ jscai.org/article/S2772-9303… @SamHorrMD @keithppereira @jaygirimd @SameerKhandhar @AzeneMD @wissamj123 @carin_gonsalves @StefanStortecky #LBMT #CostEffective #JSCAI #PEERLESS

📖Improving #PCI safety & efficiency through cath lab #CQI implementation: #AKI ↓ (14.3%→9.7%), Hgb drop ↓ (0.65→0.54 g/dL), &same-day discharge ↑ (13.0%→24.7%). ➡️jscai.org/article/S2772-9303… #RadialFirst #samedaydischarge @hsuradi

Featured in @CardioBusiness : Helena Smith and @EricSecemskyMD’s @MyJSCAI editorial describes the potential value of optical coherence tomography (OCT) in below-the-knee endovascular interventions. 🔗 Read the full editorial here: jscai.org/article/S2772-9303…

🚨 Grateful to share that our new paper on DAPT duration after acute coronary syndrome has been published in Cardiovascular Revascularization Medicine! 📈 Across 7 RCTs and 17,515 ACS patients, 3-month DAPT followed by monotherapy performed just as well as 12-month therapy for ischemic protection, while meaningfully reducing bleeding. ✅ Key findings: MACCE: 5.6% vs 5.7% (RR 0.96; 95% CI 0.79–1.17) — no difference Clinically relevant bleeding: 3.0% vs 4.9% (RR 0.62; 95% CI 0.50–0.76) — a 38% relative risk reduction, NNT of 52 Net adverse clinical events: 7.9% vs 9.7% (RR 0.81; 95% CI 0.66–1.00) 💡 Trial sequential analysis found: Conclusive evidence of futility for added ischemic benefit with longer DAPT Conclusive evidence of benefit for bleeding reduction with abbreviated DAPT 🙏 Grateful to Drs. @IbebuoguMD , @DrDrewKleinPHI , @tristonsmithmd , and Sudhir Mungee for their mentorship and guidance throughout this project, and to my co-authors for their contributions! [@louise_orth ,@sahmIbrah]

Which sheath do you utilize for single-access PCI? In our recent novel study @MyJSCAI, we characterize the mechanics of commonly utilized sheaths for single-access PCI including @jjmt_heartrecov #Abiomed Companion Sheath. jscai.org/article/S2772-9303…

🫀 Explore the latest research and expert perspectives shaping #CardiogenicShock care in a new @MyJSCAI Editor-in-Chief curated collection. Dive into advances in mechanical circulatory support, emerging treatment strategies, and innovations in complex care. Explore the collection ➡️ jscai.org/Cardiogenic-Shock #InterventionalCardiology @AlexandraLansky

📰 The newest issue of @MyJSCAI is out now! Stay current with the latest #InterventionalCardiology research, clinical insights, and emerging evidence from experts around the world—all fully Gold Open Access. Explore the latest issue ➡️ jscai.org/current

Excited to share our new review in @MyJSCAI! 🫀 Transcatheter Aortic Valve Migration and Embolization During TAVR: a contemporary management review with a practical bailout algorithm. #TAVR #StructuralHeart #InterventionalCardiology doi.org/10.1016/j.jscai.2026…

In @MyJSCAI, @RadiologyUcla's Dr. @JonnyMoriarty & collaborators profile 11,612 pulmonary embolism patients across 54 US sites, most at intermediate risk, in one of the largest real-world PE datasets yet. doi.org/10.1016/j.jscai.2026…